These are challenging times, and we are deeply grateful to our friends in the healthcare community bravely battling the Corona virus. It is a natural consequence of this crisis that elective surgeries need to be postponed, which of course we fully support.
Episurf Medical recently completed a financing round, preparing the company for additional clinical trials and continued commercialisation. In recent weeks, we have seen positive early results from two important clinical trials in Europe. These results further reinforce our view that the Episealer® knee implant technology is an ideal treatment solution for middle-aged patients suffering from severe knee pain but not yet ready for total knee replacement. In this newsletter, you can read more about recent events at our company.
To date, about 700 patients in Europe have been treated with Episealer implants, with very promising clinical results, in some cases for longer than seven years. Our company is developing well, and more and more patients can benefit from our implant technology. We are looking forward to staying in touch.
Chief Executive Officer, Episurf Medical
We plan to host our 4th dedicated Episealer Masterclass later this year. We follow the progress of the Corona virus situation and we will decide on a date for the Masterclass when the situation has stabilised. Please keep in touch with your Episurf representative and we will make sure you are informed once we have an update about the date.
M.Högström, M.D. Ph.D. presenting at the 6th Annual Meeting of the UK Biological Knee Society
At the 6th Annual Meeting of the UK Biological Knee Society Meeting on January 30-31, in Cambridge, the United Kingdom, M.D. Ph.D. M. Högström at Sports Medicine Umeå, Sweden, was invited to give the presentation “Metal Mini Prosthesis for Focal Chondral Lesions”. The presentation was based on the clinical results from a European multicenter study with patients in the “gap age”, 35-60 years old, that have undergone treatment of focal chondral defects using the knee implant Episealer. Results presented below.
Metal Mini Prosthesis for Focal Chondral Lesions
In recent weeks, Episurf Medical has published several relevant news.
Please press on the links below to access the most relevant press releases:
Positive preliminary results from first comparative study with the Episealer® Knee implant
Positive results from follow-up of 30 patients in a Swedish multi-centre clinical trial of the Episealer® Knee implant
Progress for European sites in Episurf Medical’s Episealer® knee implant IDE study